Cargando…

Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal range

BACKGROUND: Creatine kinase (CK) values are a critical part of the workup of suspected myopathies and are often assessed in patients that develop myalgia on statin therapy. CK elevations may influence the initiation and cessation of statin treatment, and incidentally discovered CK elevation may lead...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Michael D., McGill, Neilia-Kay, Baker, Joshua F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370787/
https://www.ncbi.nlm.nih.gov/pubmed/27537560
http://dx.doi.org/10.1097/MD.0000000000004344
_version_ 1782518296480841728
author George, Michael D.
McGill, Neilia-Kay
Baker, Joshua F.
author_facet George, Michael D.
McGill, Neilia-Kay
Baker, Joshua F.
author_sort George, Michael D.
collection PubMed
description BACKGROUND: Creatine kinase (CK) values are a critical part of the workup of suspected myopathies and are often assessed in patients that develop myalgia on statin therapy. CK elevations may influence the initiation and cessation of statin treatment, and incidentally discovered CK elevation may lead to further testing. A number of factors influence CK levels in healthy patients, but current reference ranges do not incorporate important influencers of CK such as race. Objectives of this study were to evaluate clinical factors associated with CK among healthy individuals and to develop practical reference ranges for important subgroups to improve test interpretation. METHODS: CK was evaluated in nonpregnant participants ≥20 years old from the cross-sectional National Health and Nutrition Examination Survey (NHANES) 2011–2014. Linear and logistic regression stratified by sex identified clinical factors associated with CK levels. Adjustment for anthropomorphic measures assessed whether age and race-ethnicity differences in CK were explained by differences in body composition. The 95th and 97.5th percentiles of CK in sex/race-ethnicity subgroups were calculated, excluding patients with recent strenuous exercise. RESULTS: A total of 10,096 nonpregnant adults were studied. Black race was strongly associated with CK. The odds ratio of having an abnormal CK for black women was 5.08 (95% CI 3.65–7.08) and for black men was 8.39 (95% CI 6.11–11.52). CK was substantially lower in older men. Differences in CK by age but not race-ethnicity were largely explained by body composition. Women with low body mass index were less likely to have an elevated CK, and overweight or obese men had an almost 2-fold greater odds of having an elevated CK. The 97.5th percentile of CK was 382 (95% CI 295–469) in white men, 1001 (95% CI 718–1284) in black men, 295 (95% CI 216–374) in white women, and 487 (95% CI 310–664) in black women. CONCLUSION: CK is substantially higher in men and in black patients. Differences in body size and composition are also important but do not explain racial differences in CK. The 95th and 97.5th percentiles in sex and race-ethnicity subgroups provide a practical guide for clinicians interpreting CK values.
format Online
Article
Text
id pubmed-5370787
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-53707872017-03-31 Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal range George, Michael D. McGill, Neilia-Kay Baker, Joshua F. Medicine (Baltimore) 4400 BACKGROUND: Creatine kinase (CK) values are a critical part of the workup of suspected myopathies and are often assessed in patients that develop myalgia on statin therapy. CK elevations may influence the initiation and cessation of statin treatment, and incidentally discovered CK elevation may lead to further testing. A number of factors influence CK levels in healthy patients, but current reference ranges do not incorporate important influencers of CK such as race. Objectives of this study were to evaluate clinical factors associated with CK among healthy individuals and to develop practical reference ranges for important subgroups to improve test interpretation. METHODS: CK was evaluated in nonpregnant participants ≥20 years old from the cross-sectional National Health and Nutrition Examination Survey (NHANES) 2011–2014. Linear and logistic regression stratified by sex identified clinical factors associated with CK levels. Adjustment for anthropomorphic measures assessed whether age and race-ethnicity differences in CK were explained by differences in body composition. The 95th and 97.5th percentiles of CK in sex/race-ethnicity subgroups were calculated, excluding patients with recent strenuous exercise. RESULTS: A total of 10,096 nonpregnant adults were studied. Black race was strongly associated with CK. The odds ratio of having an abnormal CK for black women was 5.08 (95% CI 3.65–7.08) and for black men was 8.39 (95% CI 6.11–11.52). CK was substantially lower in older men. Differences in CK by age but not race-ethnicity were largely explained by body composition. Women with low body mass index were less likely to have an elevated CK, and overweight or obese men had an almost 2-fold greater odds of having an elevated CK. The 97.5th percentile of CK was 382 (95% CI 295–469) in white men, 1001 (95% CI 718–1284) in black men, 295 (95% CI 216–374) in white women, and 487 (95% CI 310–664) in black women. CONCLUSION: CK is substantially higher in men and in black patients. Differences in body size and composition are also important but do not explain racial differences in CK. The 95th and 97.5th percentiles in sex and race-ethnicity subgroups provide a practical guide for clinicians interpreting CK values. Wolters Kluwer Health 2016-08-19 /pmc/articles/PMC5370787/ /pubmed/27537560 http://dx.doi.org/10.1097/MD.0000000000004344 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a work of the United States Government for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.
spellingShingle 4400
George, Michael D.
McGill, Neilia-Kay
Baker, Joshua F.
Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal range
title Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal range
title_full Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal range
title_fullStr Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal range
title_full_unstemmed Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal range
title_short Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal range
title_sort creatine kinase in the u.s. population: impact of demographics, comorbidities, and body composition on the normal range
topic 4400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370787/
https://www.ncbi.nlm.nih.gov/pubmed/27537560
http://dx.doi.org/10.1097/MD.0000000000004344
work_keys_str_mv AT georgemichaeld creatinekinaseintheuspopulationimpactofdemographicscomorbiditiesandbodycompositiononthenormalrange
AT mcgillneiliakay creatinekinaseintheuspopulationimpactofdemographicscomorbiditiesandbodycompositiononthenormalrange
AT bakerjoshuaf creatinekinaseintheuspopulationimpactofdemographicscomorbiditiesandbodycompositiononthenormalrange